Select Publications
Journal articles
2015, 'Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series', Journal of Autoimmunity, 57, pp. 24 - 29, http://dx.doi.org/10.1016/j.jaut.2014.11.004
,2015, 'Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: A systematic review and consensus statement', Critical Care Medicine, 43, pp. 461 - 472, http://dx.doi.org/10.1097/CCM.0000000000000708
,2015, 'Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease', Journal of Autoimmunity, 57, pp. 60 - 65, http://dx.doi.org/10.1016/j.jaut.2014.11.009
,2015, 'A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics', Critical care (London, England), 19, pp. 84, http://dx.doi.org/10.1186/s13054-015-0818-8
,2015, 'Extracorporeal treatment for lithium poisoning: Systematic review and recommendations from the EXTRIP workgroup', Clinical Journal of the American Society of Nephrology, 10, pp. 875 - 887, http://dx.doi.org/10.2215/CJN.10021014
,2015, 'Extracorporeal treatment for metformin poisoning: Systematic review and recommendations from the extracorporeal treatments in poisoning workgroup', Critical Care Medicine, 43, pp. 1716 - 1730, http://dx.doi.org/10.1097/CCM.0000000000001002
,2015, 'Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration', International Journal of Antimicrobial Agents, 46, pp. 39 - 44, http://dx.doi.org/10.1016/j.ijantimicag.2015.02.014
,2015, 'The authors reply', Critical Care Medicine, 43, pp. e534 - e535, http://dx.doi.org/10.1097/CCM.0000000000001248
,2014, 'Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: Can we resolve this problem with pharmacokinetic studies and dosing guidelines?', Critical Care, 18, http://dx.doi.org/10.1186/cc13939
,2014, 'The enigma of metformin-associated lactic acidosis', Clinical Toxicology, 52, pp. 85 - 87, http://dx.doi.org/10.3109/15563650.2014.880174
,2014, 'A stepwise approach for the management of poisoning with extracorporeal treatments', Seminars in Dialysis, 27, pp. 362 - 370, http://dx.doi.org/10.1111/sdi.12228
,2014, 'Case reports of extracorporeal treatments in poisoning: Historical trends', Seminars in Dialysis, 27, pp. 402 - 406, http://dx.doi.org/10.1111/sdi.12245
,2014, 'Diuretics', , 35, pp. 387 - 396, http://dx.doi.org/10.1016/B978-0-444-62635-6.00021-8
,2014, 'Extracorporeal treatment for tricyclic antidepressant poisoning: Recommendations from the EXTRIP workgroup', Seminars in Dialysis, 27, pp. 381 - 389, http://dx.doi.org/10.1111/sdi.12227
,2014, 'Guidelines for reporting case studies on extracorporeal treatments in poisonings: Methodology', Seminars in Dialysis, 27, pp. 407 - 414, http://dx.doi.org/10.1111/sdi.12251
,2014, 'Hemoperfusion for the treatment of poisoning: Technology, determinants of poison clearance, and application in clinical practice', Seminars in Dialysis, 27, pp. 350 - 361, http://dx.doi.org/10.1111/sdi.12246
,2014, 'Principles and operational parameters to optimize poison removal with extracorporeal treatments', Seminars in Dialysis, 27, pp. 371 - 380, http://dx.doi.org/10.1111/sdi.12247
,2014, 'The influence of acute kidney injury on antimicrobial dosing in critically ill patients: Are dose reductions always necessary?', Diagnostic Microbiology and Infectious Disease, 79, pp. 77 - 84, http://dx.doi.org/10.1016/j.diagmicrobio.2014.01.015
,2014, 'Variability in the Management of Lithium Poisoning', Seminars in Dialysis, 27, pp. 390 - 394, http://dx.doi.org/10.1111/sdi.12235
,2013, 'Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012', Drug Safety, 36, pp. 953 - 980, http://dx.doi.org/10.1007/s40264-013-0084-0
,2013, 'Non-tuberculous mycobacterial PD peritonitis in Australia', International Urology and Nephrology, 45, pp. 1423 - 1428, http://dx.doi.org/10.1007/s11255-012-0328-4
,2013, 'Amanita phalloides poisoning and treatment with silibinin in the Australian capital territory and New South Wales', Medical Journal of Australia, 198, pp. 43 - 47, http://dx.doi.org/10.5694/mja12.11180
,2013, 'Intraperitoneal voriconazole in a patient with Aspergillus peritoneal dialysis peritonitis', Peritoneal Dialysis International, 33, pp. 92 - 93, http://dx.doi.org/10.3747/pdi.2012.00023
,2013, 'Quantifying the effect of rituximab on changes in serum immunoglobulin G', La Presse Médicale, 42, pp. 766 - 767, http://dx.doi.org/10.1016/j.lpm.2013.02.272
,2013, 'The role of metformin in metformin-associated lactic acidosis (MALA): Case series and formulation of a model of pathogenesis', Drug Safety, 36, pp. 733 - 746, http://dx.doi.org/10.1007/s40264-013-0038-6
,2012, 'The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review', Transplantation, 94, pp. 775 - 783, http://dx.doi.org/10.1097/TP.0b013e31825d1587
,2012, 'Extracorporeal treatment for thallium poisoning: Recommendations from the EXTRIP workgroup', Clinical Journal of the American Society of Nephrology, 7, pp. 1682 - 1690, http://dx.doi.org/10.2215/CJN.01940212
,2012, 'Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: Case report and review of the literature', BMC Nephrology, 13, http://dx.doi.org/10.1186/1471-2369-13-35
,2012, 'The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup: Guideline methodology', Clinical Toxicology, 50, pp. 403 - 413, http://dx.doi.org/10.3109/15563650.2012.683436
,2012, 'Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: A multicentre pharmacokinetic study', Critical Care Medicine, 40, pp. 1523 - 1528, http://dx.doi.org/10.1097/CCM.0b013e318241e553
,2012, 'Obstructive nephropathy secondary to a massive vesical calculus', Internal Medicine Journal, 42, pp. 471 - 472, http://dx.doi.org/10.1111/j.1445-5994.2012.02735.x
,2012, 'Lead mobilization study and the clearance of intravenous CaNa
2012, 'Metformin therapy in patients with chronic kidney disease', Diabetes Obesity and Metabolism, 14, pp. 963 - 965, http://dx.doi.org/10.1111/j.1463-1326.2012.01617.x
,2012, 'Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease', British Journal of Clinical Pharmacology, 73, pp. 828 - 829, http://dx.doi.org/10.1111/j.1365-2125.2011.04147.x
,2011, 'The relevance of drug clearance to antibiotic dosing in critically Ill patients', Current Pharmaceutical Biotechnology, 12, pp. 2002 - 2014, http://dx.doi.org/10.2174/138920111798808374
,2011, 'Simultaneous quantification of carbamate insecticides in human plasma by liquid chromatography/tandem mass spectrometry', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 879, pp. 2234 - 2238, http://dx.doi.org/10.1016/j.jchromb.2011.06.006
,2011, 'Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration.', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26, pp. 3344 - 3349, http://dx.doi.org/10.1093/ndt/gfr005
,2011, 'Death and morbidity from supratherapeutic dosing of colchicine', Medical Journal of Australia, 194, pp. 612 - 613, http://dx.doi.org/10.5694/j.1326-5377.2011.tb03121.x
,2011, 'More data on the effect of haemoperfusion for acute poisoning is required', Blood Purification, 31, pp. 41, http://dx.doi.org/10.1159/000321888
,2011, 'Acute kidney injury due to crystalluria following acute valacycolvir overdose', Kidney International, 79, pp. 574 - 575, http://dx.doi.org/10.1038/ki.2010.496
,2011, 'Changes in the concentrations of creatinine, cystatin C and NGAL in patients with acute paraquat self-poisoning', Toxicology Letters, 202, pp. 69 - 74, http://dx.doi.org/10.1016/j.toxlet.2011.01.024
,2011, 'Enhanced elimination in acute barbiturate poisoning –A systematic review', Clinical Toxicology, 4, pp. 2 - 12
,2011, 'Extreme y-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis', Annals of Emergency Medicine, 58, pp. 83 - 85, http://dx.doi.org/10.1016/j.annemergmed.2011.01.017
,2011, 'Toxicokinetics, including saturable protein binding, of 4-chloro-2-methyl phenoxyacetic acid (MCPA) in patients with acute poisoning', Toxicology Letters, 201, pp. 270 - 276, http://dx.doi.org/10.1016/j.toxlet.2011.01.011
,2010, 'ENHANCED ELIMINATION OF PHENOBARBITAL USING CHARCOAL HAEMOPERFUSION IN A PATIENT WITH SEVERE POISONING', NEPHROLOGY, 15, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Availability of antidotes for the treatment of acute poisoning in Queensland public hospitals', Australian Journal of Rural Health, 18, pp. 78 - 84, http://dx.doi.org/10.1111/j.1440-1584.2010.01129.x
,2010, 'Acute human self-poisoning with bispyribac-containing herbicide Nominee®: A prospective observational study', Clinical Toxicology, 48, pp. 198 - 202, http://dx.doi.org/10.3109/15563651003660000
,2010, 'Management of renal bone disease', Australian Prescriber, 33, pp. 34 - 37, http://dx.doi.org/10.18773/austprescr.2010.016
,2010, 'A prospective observational study of the clinical toxicology of glyphosate-containing herbicides in adults with acute self-poisoning', Clinical Toxicology (Philadelphia, Pa.), 48, pp. 129 - 136, http://dx.doi.org/10.3109/15563650903476491
,2009, 'Factors influencing variability in clinical outcomes from imidacloprid self-poisoning', Clinical Toxicology, 47, pp. 836 - 837, http://dx.doi.org/10.1080/15563650903210416
,